BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

560 related articles for article (PubMed ID: 23132518)

  • 1. Spotlight on 'xeroderma pigmentosum'.
    Fassihi H
    Photochem Photobiol Sci; 2013 Jan; 12(1):78-84. PubMed ID: 23132518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Xeroderma pigmentosum genes: functions inside and outside DNA repair.
    Sugasawa K
    Carcinogenesis; 2008 Mar; 29(3):455-65. PubMed ID: 18174245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Xeroderma pigmentosum].
    Ueda M; Ichihashi M
    Nihon Rinsho; 1995 Nov; 53(11):2815-20. PubMed ID: 8538050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Xeroderma pigmentosum.
    Lehmann AR; McGibbon D; Stefanini M
    Orphanet J Rare Dis; 2011 Nov; 6():70. PubMed ID: 22044607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rare exon 10 deletion in POLH gene in a family with xeroderma pigmentosum variant correlating with protein expression by immunohistochemistry.
    Borroni RG; Diegoli M; Grasso M; Concardi M; Agozzino M; Vignini M; Arbustini E
    G Ital Dermatol Venereol; 2020 Jun; 155(3):349-354. PubMed ID: 32635709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Common pathways for ultraviolet skin carcinogenesis in the repair and replication defective groups of xeroderma pigmentosum.
    Cleaver JE
    J Dermatol Sci; 2000 May; 23(1):1-11. PubMed ID: 10699759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Persistence of repair proteins at unrepaired DNA damage distinguishes diseases with ERCC2 (XPD) mutations: cancer-prone xeroderma pigmentosum vs. non-cancer-prone trichothiodystrophy.
    Boyle J; Ueda T; Oh KS; Imoto K; Tamura D; Jagdeo J; Khan SG; Nadem C; Digiovanna JJ; Kraemer KH
    Hum Mutat; 2008 Oct; 29(10):1194-208. PubMed ID: 18470933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complementation of the DNA repair deficiency in human xeroderma pigmentosum group a and C cells by recombinant adenovirus-mediated gene transfer.
    Muotri AR; Marchetto MC; Zerbini LF; Libermann TA; Ventura AM; Sarasin A; Menck CF
    Hum Gene Ther; 2002 Oct; 13(15):1833-44. PubMed ID: 12396616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Xeroderma pigmentosum--bridging a gap between clinic and laboratory.
    Moriwaki S; Kraemer KH
    Photodermatol Photoimmunol Photomed; 2001 Apr; 17(2):47-54. PubMed ID: 11338401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenovirus mediated transduction of the human DNA polymerase eta cDNA.
    Lima-Bessa KM; Chiganças V; Stary A; Kannouche P; Sarasin A; Armelini MG; de Fátima Jacysyn J; Amarante-Mendes GP; Cordeiro-Stone M; Cleaver JE; Menck CF
    DNA Repair (Amst); 2006 Aug; 5(8):925-34. PubMed ID: 16798111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between DNA repair-deficiency and high level of p53 mutations in melanoma of Xeroderma pigmentosum.
    Spatz A; Giglia-Mari G; Benhamou S; Sarasin A
    Cancer Res; 2001 Mar; 61(6):2480-6. PubMed ID: 11289118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High incidence of ultraviolet-B-or chemical-carcinogen-induced skin tumours in mice lacking the xeroderma pigmentosum group A gene.
    Nakane H; Takeuchi S; Yuba S; Saijo M; Nakatsu Y; Murai H; Nakatsuru Y; Ishikawa T; Hirota S; Kitamura Y
    Nature; 1995 Sep; 377(6545):165-8. PubMed ID: 7675085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical, genetic and DNA repair studies on a consecutive series of patients with xeroderma pigmentosum.
    Pawsey SA; Magnus IA; Ramsay CA; Benson PF; Giannelli F
    Q J Med; 1979 Apr; 48(190):179-210. PubMed ID: 504548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Requirement for functional DNA polymerase eta in genome-wide repair of UV-induced DNA damage during S phase.
    Auclair Y; Rouget R; Belisle JM; Costantino S; Drobetsky EA
    DNA Repair (Amst); 2010 Jul; 9(7):754-64. PubMed ID: 20457011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel mutation in the XPA gene associated with unusually mild clinical features in a patient who developed a spindle cell melanoma.
    Sidwell RU; Sandison A; Wing J; Fawcett HD; Seet JE; Fisher C; Nardo T; Stefanini M; Lehmann AR; Cream JJ
    Br J Dermatol; 2006 Jul; 155(1):81-8. PubMed ID: 16792756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Xeroderma pigmentosa: three new cases with an in depth review of the genetic and clinical characteristics of the disease.
    Karass M; Naguib MM; Elawabdeh N; Cundiff CA; Thomason J; Steelman CK; Cone R; Schwenkter A; Jordan C; Shehata BM
    Fetal Pediatr Pathol; 2015 Apr; 34(2):120-7. PubMed ID: 25454817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Xeroderma pigmentosum: from symptoms and genetics to gene-based skin therapy.
    Magnaldo T; Sarasin A
    Cells Tissues Organs; 2004; 177(3):189-98. PubMed ID: 15388993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of effective skin cancer treatment and prevention in xeroderma pigmentosum.
    Lambert WC; Lambert MW
    Photochem Photobiol; 2015; 91(2):475-83. PubMed ID: 25382223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Xeroderma pigmentosum group E and DDB2, a smaller subunit of damage-specific DNA binding protein: proposed classification of xeroderma pigmentosum, Cockayne syndrome, and ultraviolet-sensitive syndrome.
    Itoh T
    J Dermatol Sci; 2006 Feb; 41(2):87-96. PubMed ID: 16325378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular genetics of Xeroderma pigmentosum variant.
    Gratchev A; Strein P; Utikal J; Sergij G
    Exp Dermatol; 2003 Oct; 12(5):529-36. PubMed ID: 14705792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.